Solifenacin succinate / tamsulosin hydrochloride

Details

Files

Generic Name:

Project Status:

Withdrawn

Therapeutic Area:

Benign prostatic hyperplasia

Manufacturer:

Astellas Pharma Canada, Inc.

Call for patient/clinician input open:

March 2, 2015

Brand Name:

VesiFlow

Project Line:

Reimbursement Review

Project Number:

SR0424-000

Call for patient/clinician input closed:

April 21, 2015

Submission Type:

Initial

Indications:

Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms

Last Updated : March 2, 2015